Per Samuelsson, MSc
Per Samuelsson was appointed to the board of Oncopeptides in 2012.
Per is a partner at HealthCap, a life sciences venture capital business.
Per has 22 years of experience from investing venture capital in the life science sector. Before that, Per gained over 15 years of investment banking experience, mainly with Aros Securities based in Sweden. At Aros Securities he held several roles including being a Director in the corporate finance department where he specialized in merger transactions, initial public offerings and equity incentive programs. Per also held the role of Head of Research at Aros Securities.
Per holds an MSc in Engineering from the Institute of Technology in Linköping, Sweden.
Board Committees: Member of the Audit Committee and the Remuneration Committee
Holdings in Oncopeptides: –
Other current positions: Board Member of Ariceum Therapeutics GmbH, Cantando AB, Cantando Holding AB, HealthCap AB, HealthCap Annex Fund I-II GP AB, Pretzel Therapeutics, Inc., Skipjack AB.
Independent in relation to the Company and its senior management, but not in relation to major shareholders. Partner in HealthCap and holder of directorships in several companies within the HealthCap Group.